Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Statistical Methods in Medical Research
|
August 24, 2017
Improved conditional imputation for linear regression with a randomly censored predictor
Folefac D Atem, Emmanuel Sampene, Thomas J Greene
Statistics in Medicine
|
December 22, 2020
A machine learning compatible method for ordinal propensity score stratification and matching
Thomas J Greene, Stacia M DeSantis, Derek W Brown, et al.
Statistics in Medicine
|
December 11, 2020
Propensity score stratification methods for continuous treatments
Derek W Brown, Thomas J Greene, Michael D Swartz, et al.
Pharmacology Research & Perspectives
|
June 3, 2023
A phase I, first-in-human study investigating the safety, tolerability, and pharmacokinetics of the maturation inhibitor GSK3739937
Paul D Benn, Ying Zhang, Lesley Kahl, et al.
Military Medicine
|
April 11, 2018
Utilizing Propensity Score Analyses in Prehospital Blood Product Transfusion Studies: Lessons Learned and Moving Toward Best Practice
Thomas J Greene, Stacia M DeSantis, Erin E Fox, et al.
Statistics in Medicine
|
April 17, 2020
A novel approach for propensity score matching and stratification for multiple treatments: Application to an electronic health record-derived study
Derek W Brown, Stacia M DeSantis, Thomas J Greene, et al.
British Journal of Clinical Pharmacology
|
February 3, 2021
Phase I evaluation of pharmacokinetics and tolerability of the HIV-1 maturation inhibitor GSK3640254 and dolutegravir in healthy adults
Teodora Pene Dumitrescu, Samit R Joshi, Jianfeng Xu, et al.
British Journal of Clinical Pharmacology
|
August 24, 2021
Lack of pharmacokinetic interaction between the HIV-1 maturation inhibitor GSK3640254 and combination oral contraceptives in healthy women
Teodora Pene Dumitrescu, Thomas J Greene, Samit R Joshi, et al.
Pharmacology Research & Perspectives
|
November 17, 2020
Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next-generation HIV-1 maturation inhibitor
Samit R Joshi, Disala Fernando, Stephanie Igwe, et al.
Rheumatology and Therapy
|
March 17, 2026
Efficacy and Safety of Obexelimab to Treat IgG4-Related Disease: Protocol for a Global, Randomized, Placebo-Controlled Trial
Emma L Culver, Matthew C Baker, Emanuel Della-Torre, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Statistical Methods in Medical Research
|
August 24, 2017
Improved conditional imputation for linear regression with a randomly censored predictor
Folefac D Atem, Emmanuel Sampene, Thomas J Greene
Statistics in Medicine
|
December 22, 2020
A machine learning compatible method for ordinal propensity score stratification and matching
Thomas J Greene, Stacia M DeSantis, Derek W Brown, et al.
Statistics in Medicine
|
December 11, 2020
Propensity score stratification methods for continuous treatments
Derek W Brown, Thomas J Greene, Michael D Swartz, et al.
Pharmacology Research & Perspectives
|
June 3, 2023
A phase I, first-in-human study investigating the safety, tolerability, and pharmacokinetics of the maturation inhibitor GSK3739937
Paul D Benn, Ying Zhang, Lesley Kahl, et al.
Military Medicine
|
April 11, 2018
Utilizing Propensity Score Analyses in Prehospital Blood Product Transfusion Studies: Lessons Learned and Moving Toward Best Practice
Thomas J Greene, Stacia M DeSantis, Erin E Fox, et al.
Statistics in Medicine
|
April 17, 2020
A novel approach for propensity score matching and stratification for multiple treatments: Application to an electronic health record-derived study
Derek W Brown, Stacia M DeSantis, Thomas J Greene, et al.
British Journal of Clinical Pharmacology
|
February 3, 2021
Phase I evaluation of pharmacokinetics and tolerability of the HIV-1 maturation inhibitor GSK3640254 and dolutegravir in healthy adults
Teodora Pene Dumitrescu, Samit R Joshi, Jianfeng Xu, et al.
British Journal of Clinical Pharmacology
|
August 24, 2021
Lack of pharmacokinetic interaction between the HIV-1 maturation inhibitor GSK3640254 and combination oral contraceptives in healthy women
Teodora Pene Dumitrescu, Thomas J Greene, Samit R Joshi, et al.
Pharmacology Research & Perspectives
|
November 17, 2020
Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next-generation HIV-1 maturation inhibitor
Samit R Joshi, Disala Fernando, Stephanie Igwe, et al.
Rheumatology and Therapy
|
March 17, 2026
Efficacy and Safety of Obexelimab to Treat IgG4-Related Disease: Protocol for a Global, Randomized, Placebo-Controlled Trial
Emma L Culver, Matthew C Baker, Emanuel Della-Torre, et al.
Page
of 2